Sellas Life Sciences Group Inc expected to post a loss of 10 cents a share - Earnings Preview

Sellas Life Sciences

09/05/2025 12:47

Sellas Life Sciences Group Inc SLS.OQ SLS.O is expected to report resultson May 12 (estimated) for the period ending March 31 2025

​LSEG's mean analyst estimate for Sellas Life Sciences Group Inc is for a loss of 10 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Sellas Life Sciences Group Inc is $6.00​, above​ its last closing price of $1.68. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATEÂŪ
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Dec. 31 2024
-0.11
-0.11
-0.08
Beat
25.5
Sep. 30 2024
-0.14
-0.13
-0.10
Beat
23.1
Jun. 30 2024
-0.17
-0.16
-0.13
Beat
21.2​
Mar. 31 2024
-0.16
-0.16
-0.21
Missed
-31.2
​​Dec. 31 2023
-0.27
0.00
-0.25
Missed
-8,990.9
Sep. 30 2023
0.03
0.03
-0.33
Missed
-1,200​
Jun. 30 2023
-0.34
-0.35
-0.31
Beat
12.7
Mar. 31 2023
-0.29
-0.29
-0.47
Missed
-61.1

This summary was machine generated May 9 at 11:47 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)